Marker Therapeutics, Inc.Marker Therapeutics, Inc.Marker Therapeutics, Inc.

Marker Therapeutics, Inc.

No trades
See on Supercharts

MRKR fundamentals

Marker Therapeutics, Inc. earnings per share and revenue

MRKR earnings per share for the last quarter are -0.25 USD whereas the estimation was -0.43 USD which accounts for 41.98% surprise. Estimated earnings per share for the next quarter are -0.39 USD, and revenue is expected to reach 1.00 M USD. Also watch annual changes over time to get a bigger picture of MRKR earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise